Schering-Plough launches Clarinex DTC advertising campaign March 4 with full-page ads in The New York Times and The Washington Post. The television, online and print ad campaign, timed to coincide with the spring allergy season, could reach "over 45 million Americans," says marketing partner AOL Time Warner. Clarinex has a 12.3% new prescription share as of Feb. 25, up from 10.8% the previous week, Schering told analysts Feb. 26. Promotions for the drug include a seven-day coupon, distributed in lieu of sample
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The program would allow early interactions with FDA staff to speed construction and approval of pharmaceutical manufacturing facilities in the US, but will staff be available?
The importance of generic and biosimilar medicines is being recognized by the UK government for the first time. However, Mark Samuels, CEO of Medicines UK, the trade body representing the off-patent industry, says companies are still face multiple hurdles in the market.
The UK drug regulator is collecting data to establish whether patients who are hospitalized for acute pancreatitis after taking a GLP-1 drug have a genetic predisposition to this side effect. If a “clear link” is found, the MHRA would consider regulatory action.